S
Søren Cold
Researcher at Odense University Hospital
Publications - 63
Citations - 2807
Søren Cold is an academic researcher from Odense University Hospital. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 27, co-authored 59 publications receiving 2388 citations. Previous affiliations of Søren Cold include University of Southern Denmark.
Papers
More filters
Journal ArticleDOI
Effect of Obesity on Prognosis After Early-Stage Breast Cancer
Marianne Ewertz,Maj-Britt Jensen,Katrín Á Gunnarsdóttir,Inger Højris,Erik Jakobsen,Dorte Nielsen,Lars Stenbygaard,Ulla Brix Tange,Søren Cold +8 more
TL;DR: Obesity is an independent prognostic factor for developing distant metastases and for death as a result of breast cancer; the effects of adjuvant therapy seem to be lost more rapidly in patients with breast cancer and obesity.
Journal ArticleDOI
Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer
Kristina Pilekær Sørensen,Kristina Pilekær Sørensen,Mads Thomassen,Mads Thomassen,Qihua Tan,Qihua Tan,Martin Bak,Søren Cold,Mark Burton,Mark Burton,Martin Jakob Larsen,Martin Jakob Larsen,Torben A Kruse,Torben A Kruse +13 more
TL;DR: HOTAIR expression may serve as an independent biomarker for the prediction of the risk of metastasis in ER-positive breast cancer patients, and is successfully validated in an independent dataset with similar associations.
Journal ArticleDOI
The postmastectomy pain syndrome: an epidemiological study on the prevalence of chronic pain after surgery for breast cancer
TL;DR: Although recent advances in the diagnostic and surgical procedures have reduced the frequency of the more invasive surgical procedures, there still is a considerable risk of developing postmastectomy pain syndrome after treatment of breast cancer.
Journal ArticleDOI
Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: A case control study
Annette R Kodahl,Annette R Kodahl,Maria Bibi Lyng,Harald Binder,Søren Cold,Søren Cold,Karina H Gravgaard,Ann Knoop,Henrik J. Ditzel,Henrik J. Ditzel +9 more
TL;DR: The aim of this study was to investigate the differential expression of miRNAs in the serum of breast cancer patients and healthy controls.
Journal ArticleDOI
Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer? Results of the Danish Breast Cancer Cooperative Group (DBCG)
TL;DR: There is no evidence for a survival benefit due to early initiation of adjuvant chemotherapy within the first 2–3 months after surgery, and there was no pattern indicating a benefit from early start of chemotherapy.